These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 28351734)
41. Development of novel therapeutics for chronic hepatitis B. Xie YH; Hong R; Liu W; Liu J; Zhai JW Virol Sin; 2010 Aug; 25(4):294-300. PubMed ID: 20960302 [TBL] [Abstract][Full Text] [Related]
42. Checkpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic HBV Infection. Hoogeveen RC; Boonstra A Front Immunol; 2020; 11():401. PubMed ID: 32194573 [TBL] [Abstract][Full Text] [Related]
43. Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future. Michel ML; Pol S; Brechot C; Tiollais P Vaccine; 2001 Mar; 19(17-19):2395-9. PubMed ID: 11257367 [TBL] [Abstract][Full Text] [Related]
44. Prospects and progress of DNA vaccines for treating hepatitis B. Chen M; Jagya N; Bansal R; Frelin L; Sällberg M Expert Rev Vaccines; 2016 May; 15(5):629-40. PubMed ID: 26652035 [TBL] [Abstract][Full Text] [Related]
45. Clinical Trial Design for Immune-Based Therapy of Hepatitis B Virus. Gill US; Bertoletti A Semin Liver Dis; 2017 May; 37(2):85-94. PubMed ID: 28564718 [TBL] [Abstract][Full Text] [Related]
46. [Therapeutic vaccination against chronic hepatitis B virus infection]. Mancini-Bourgine M; Michel ML Therapie; 2005; 60(3):257-65. PubMed ID: 16128268 [TBL] [Abstract][Full Text] [Related]
47. Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice. Yoon SK; Seo YB; Im SJ; Bae SH; Song MJ; You CR; Jang JW; Yang SH; Suh YS; Song JS; Kim BM; Kim CY; Jeong SH; Sung YC Liver Int; 2015 Mar; 35(3):805-15. PubMed ID: 24620920 [TBL] [Abstract][Full Text] [Related]
48. Emerging pipeline drugs for hepatitis B infection. Cox N; Tillmann H Expert Opin Emerg Drugs; 2011 Dec; 16(4):713-29. PubMed ID: 22195605 [TBL] [Abstract][Full Text] [Related]
49. Vaccine therapies for chronic hepatitis B: can we go further? Wen Y; Wang X; Wang B; Yuan Z Front Med; 2014 Mar; 8(1):17-23. PubMed ID: 24464422 [TBL] [Abstract][Full Text] [Related]
50. Hepatitis B virus infection. Liaw YF; Chu CM Lancet; 2009 Feb; 373(9663):582-92. PubMed ID: 19217993 [TBL] [Abstract][Full Text] [Related]
51. [Combination therapy of lamivudine and HB vaccine for the treatment of chronic hepatitis B]. Ishikawa T; Kakumu S Nihon Rinsho; 2004 Aug; 62 Suppl 8():331-5. PubMed ID: 15453340 [No Abstract] [Full Text] [Related]
52. [Corticosteroid withdrawal therapy in patients with chronic hepatitis B virus infection]. Akuta N; Kumada H Nihon Rinsho; 2004 Aug; 62 Suppl 8():345-8. PubMed ID: 15453343 [No Abstract] [Full Text] [Related]
53. Immunotherapy and therapeutic vaccines for chronic HBV infection. Lang-Meli J; Neumann-Haefelin C; Thimme R Curr Opin Virol; 2021 Dec; 51():149-157. PubMed ID: 34710645 [TBL] [Abstract][Full Text] [Related]
54. Molecular Mechanisms to Control Post-Transplantation Hepatitis B Recurrence. Takaki A; Yasunaka T; Yagi T Int J Mol Sci; 2015 Jul; 16(8):17494-513. PubMed ID: 26263973 [TBL] [Abstract][Full Text] [Related]
55. Therapeutic vaccination and novel strategies to treat chronic HBV infection. Bertoletti A; Gehring A Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):561-9. PubMed ID: 19817676 [TBL] [Abstract][Full Text] [Related]
58. Towards immunotherapy for chronic hepatitis B virus infections. Michel ML Vaccine; 2002 Dec; 20 Suppl 4():A83-8. PubMed ID: 12477434 [TBL] [Abstract][Full Text] [Related]
59. Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B. Fung J; Lai CL; Yuen MF Expert Rev Anti Infect Ther; 2010 Jun; 8(6):717-26. PubMed ID: 20521898 [TBL] [Abstract][Full Text] [Related]
60. Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus. Hilleman MR Vaccine; 2003 Dec; 21(32):4626-49. PubMed ID: 14585670 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]